Foundation president, Harvey Fineberg, and chairman emeritus and co-founder, Gordon Moore, discuss the Statement of Founders’ Intent with staff.
To support the development of somatic reference samples that can be used to develop and benchmark performance of molecular diagnostic tests for cancer.
Thank you for sharing.
Medical Device Innovation Consortium
$500,000
24 months
Somatic Reference Sample (SRS): Transforming Precision Medicine by Simplifying Validation
Nov 2021
Creating positive outcomes for future generations.
